Get the Stockscreener App
10.27
0.48%
-0.05
After Hours:
10.24
-0.03
-0.29%
Emergent Biosolutions Inc Stock (EBS) Forecast
The Emergent Biosolutions Inc (EBS) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $11.39, representing a +10.91% increase from the current price of $10.27. The highest analyst price target is $11.76, and the lowest is $11.02.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month EBS Price Target
Average 25.50
(+148.34% Upside)
Is Emergent Biosolutions Inc (EBS) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 65.25 | Neutral |
| STOCH(9,6) | 83.63 | Sell |
| STOCHRSI(14) | 98.77 | Sell |
| MACD(12,26) | 0.2023 | Buy |
| ADX(14) | 19.77 | Neutral |
| William %R | -10.03 | Sell |
| CCI(14) | 132.05 | Buy |
Buy: 2
Sell: 3
Neutral: 2
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
9.094
Buy
|
9.4434
Buy
|
| MA20 |
8.847
Buy
|
9.1789
Buy
|
| MA50 |
9.2736
Buy
|
9.0839
Buy
|
| MA100 |
8.8539
Buy
|
8.7296
Buy
|
| MA200 |
7.4303
Buy
|
7.5287
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, EBS could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 3 signaling Sell signals and 2 Neutral signals. This might be a good time to open fresh positions on EBS, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 65.25 indicates that EBS is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 83.63 indicates that EBS is oversold. This means that EBS price is at or near the highest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 98.77 indicates that EBS is oversold. This suggests that EBS price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 19.77 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 132.05 indicates that EBS is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term EBS price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Emergent Biosolutions Inc financial reports and earnings history, Emergent Biosolutions Inc (EBS) stock could reach $104.81 by 2030, $72.79 by 2040 and $370.25 by 2050. See the projected annual prices until 2050 of the Emergent Biosolutions Inc stock below:
- Emergent Biosolutions Inc (EBS) is expected to reach an average price of $234.41 in 2035, with a high prediction of $247.58 and a low estimate of $235.18. This indicates an $2,183% rise from the last recorded price of $10.27.
- Emergent Biosolutions Inc (EBS) stock is projected to chart a bullish course in 2040, with an average price target of $59.07, representing an $475.14% surge from its current level. The forecast ranges from a conservative $59.11 to a sky-high $72.79.
- Our analysts predict Emergent Biosolutions Inc (EBS) to jump 1,640% by 2045, soaring from $179.00 to an average price of $178.74, potentially reaching $198.61. While $179.00 is the low estimate, the potential upside is significant.
- Emergent Biosolutions Inc (EBS) stock is expected to climb by 2050, reaching an average of $347.34, a $3,282% jump from its current level. However, a wide range of estimates exists, with high and low targets of $370.25 and $347.40, respectively, highlighting the market's uncertainty.
Emergent Biosolutions Inc Stock (EBS) Year by Year Forecast
Emergent Biosolutions Inc Stock (EBS) Price Forecast for 2025
Emergent Biosolutions Inc Stock (EBS) is expected to reach an average price of $25.50 in 2025, with a high prediction of $50.65 and a low estimate of $0.3582. This indicates an +148.34% rise from the last recorded price of $10.27.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| February, 2025 | $10.84 | $11.02 | $11.76 | +5.56% |
| March, 2025 | $8.8464 | $9.1064 | $10.11 | -13.86% |
| April, 2025 | $7.4386 | $7.4436 | $8.3928 | -27.57% |
| May, 2025 | $6.0444 | $6.0744 | $6.9951 | -41.15% |
| June, 2025 | $3.2602 | $3.1537 | $3.9408 | -68.26% |
| July, 2025 | $1.8224 | $1.8824 | $2.5666 | -82.26% |
| August, 2025 | $0.8485 | $0.3582 | $1.3388 | -91.74% |
| September, 2025 | $47.86 | $29.28 | $50.65 | +366.00% |
| October, 2025 | $45.12 | $45.59 | $46.71 | +339.37% |
| November, 2025 | $42.24 | $42.75 | $42.74 | +311.34% |
| December, 2025 | $39.29 | $39.17 | $41.38 | +282.56% |
Emergent Biosolutions Inc Stock (EBS) Price Forecast for 2026
The predicted value for Emergent Biosolutions Inc (EBS) in 2026 is set at an average of $29.81. Estimates vary from a peak of $57.04 to a trough of $2.5863, indicating an +190.29% surge from the present price of $10.27.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $36.55 | $36.61 | $38.11 | +255.90% |
| February, 2026 | $35.05 | $34.65 | $35.52 | +241.31% |
| March, 2026 | $32.14 | $32.55 | $34.23 | +212.99% |
| April, 2026 | $30.06 | $30.10 | $31.21 | +192.68% |
| May, 2026 | $26.85 | $27.34 | $29.19 | +161.44% |
| June, 2026 | $23.82 | $24.00 | $25.98 | +131.95% |
| July, 2026 | $19.43 | $19.48 | $22.67 | +89.15% |
| August, 2026 | $16.70 | $16.70 | $18.24 | +62.58% |
| September, 2026 | $11.64 | $12.90 | $15.84 | +13.36% |
| October, 2026 | $8.6232 | $8.9532 | $9.9446 | -16.03% |
| November, 2026 | $5.7048 | $5.7648 | $7.6561 | -44.45% |
| December, 2026 | $58.77 | $2.5863 | $57.04 | +472.25% |
Emergent Biosolutions Inc Stock (EBS) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Emergent Biosolutions Inc (EBS) is $52.52, with a high forecast of $80.17 and a low forecast of $24.87. This indicates an +411.39% increase from the last price of $10.27.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $75.53 | $76.62 | $80.17 | +635.42% |
| February, 2027 | $72.16 | $72.93 | $72.06 | +602.67% |
| March, 2027 | $66.68 | $66.76 | $69.00 | +549.28% |
| April, 2027 | $62.61 | $62.63 | $65.06 | +509.63% |
| May, 2027 | $58.22 | $58.28 | $61.02 | +466.85% |
| June, 2027 | $54.25 | $54.60 | $56.77 | +428.26% |
| July, 2027 | $49.86 | $50.02 | $52.13 | +385.49% |
| August, 2027 | $46.35 | $46.39 | $48.42 | +351.29% |
| September, 2027 | $40.66 | $40.78 | $45.07 | +295.95% |
| October, 2027 | $35.31 | $35.69 | $38.99 | +243.83% |
| November, 2027 | $30.34 | $30.39 | $33.80 | +195.41% |
| December, 2027 | $24.87 | $24.87 | $28.74 | +142.11% |
Emergent Biosolutions Inc Stock (EBS) Price Forecast for 2028
In 2028, Emergent Biosolutions Inc (EBS) is projected to reach an average price of $57.26, with a high projection of $109.71 and a low estimate of $4.8145. This indicates an +457.55% rise from the last price of $10.27.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $18.83 | $20.09 | $23.53 | +83.37% |
| February, 2028 | $14.16 | $14.49 | $16.72 | +37.88% |
| March, 2028 | $8.3665 | $8.5864 | $12.78 | -18.53% |
| April, 2028 | $89.12 | $4.8145 | $87.39 | +767.77% |
| May, 2028 | $101.28 | $102.16 | $109.71 | +886.16% |
| June, 2028 | $97.33 | $98.18 | $99.50 | +847.73% |
| July, 2028 | $91.66 | $91.74 | $95.17 | +792.45% |
| August, 2028 | $84.58 | $84.85 | $89.62 | +723.60% |
| September, 2028 | $78.13 | $78.26 | $82.32 | +660.73% |
| October, 2028 | $73.85 | $74.20 | $75.14 | +619.09% |
| November, 2028 | $66.86 | $66.92 | $71.32 | +551.01% |
| December, 2028 | $61.29 | $61.34 | $65.01 | +496.81% |
Emergent Biosolutions Inc Stock (EBS) Price Forecast for 2029
The 2029 price forecast for Emergent Biosolutions Inc Stock (EBS) is $73.34 on average, with a high prediction of $139.64 and a low estimate of $7.0427. This represents an +614.14% increase from the previous price of $10.27.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $53.18 | $53.42 | $59.57 | +417.83% |
| February, 2029 | $46.12 | $46.30 | $51.40 | +349.11% |
| March, 2029 | $39.80 | $39.80 | $44.24 | +287.51% |
| April, 2029 | $33.71 | $33.71 | $38.00 | +228.24% |
| May, 2029 | $23.88 | $24.37 | $31.97 | +132.51% |
| June, 2029 | $18.08 | $18.12 | $21.88 | +76.07% |
| July, 2029 | $11.84 | $12.06 | $16.12 | +15.24% |
| August, 2029 | $141.56 | $7.0427 | $139.64 | +1,278% |
| September, 2029 | $129.56 | $130.44 | $139.22 | +1,162% |
| October, 2029 | $122.90 | $122.91 | $127.33 | +1,097% |
| November, 2029 | $114.55 | $115.05 | $119.83 | +1,015% |
| December, 2029 | $107.49 | $107.76 | $112.18 | +946.64% |
Emergent Biosolutions Inc Stock (EBS) Price Forecast for 2030
Emergent Biosolutions Inc Stock (EBS) is expected to reach an average price of $89.42 in 2030, with a high forecast of $169.58 and a low forecast of $9.2708. This signifies an +770.74% surge from the last price of $10.27.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $96.88 | $97.17 | $104.81 | +843.34% |
| February, 2030 | $91.23 | $91.91 | $94.60 | +788.31% |
| March, 2030 | $84.39 | $84.45 | $88.69 | +721.70% |
| April, 2030 | $77.17 | $77.22 | $82.13 | +651.39% |
| May, 2030 | $66.99 | $67.23 | $75.03 | +552.28% |
| June, 2030 | $58.28 | $58.46 | $64.79 | +467.45% |
| July, 2030 | $48.38 | $48.42 | $55.98 | +371.07% |
| August, 2030 | $40.54 | $40.60 | $46.27 | +294.72% |
| September, 2030 | $30.66 | $31.15 | $38.41 | +198.50% |
| October, 2030 | $21.02 | $21.12 | $28.25 | +104.65% |
| November, 2030 | $13.36 | $13.38 | $18.87 | +30.05% |
| December, 2030 | $171.50 | $9.2708 | $169.58 | +1,570% |
0.50%
2.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):